ChemEngg.com - Chemical Engineering Information Exchange - Directory

»Kent awarded three-year multi-site Master Services Agreement with TotalEnergies »India's May fuel consumption soars on robust manufacturing »The sustainable aviation fuel entrepreneurs poised for takeoff »Valtek Valdisk High Performance Butterfly Valve, completes million-cycle test »Neste enables Swedish airport and Västflyg airline to become the world's firsts to use SAF on all flights »EPA's proposed eRIN program raises concerns and sparks legislative action »Leak halts unit at Shell's Pernis oil refinery in Rotterdam »Germany triggers EU investigation into Chinese biofuels »thyssenkrupp Uhde awarded supply of new uhde ammonia converter cartridge including synthesis catalyst by İGSAŞ »Axens builds on ExxonMobil MTBE Decomposition Tech for high purity isobutylene production »Aramco expands petrochemical presence in China »Albemarle attempts to buy Australian lithium miner »Cinven beats Ineos to buy MBCC Admixtures »SK Chemicals buying Chinese plastic recycler »Private equity firm Apollo to buy distributor Univar »LyondellBasell may sell ethylene oxide unit »L’Oréal invests in Genomatica venture »Fragrance makers under investigation for cartel activity »CF Industries buying Louisiana ammonia plant »Albemarle to build $1.3 billion US lithium refinery »siRNA firm Switch Therapeutics enters the chat »Vertellus acquires Centauri and changes name to Aurorium »Sanofi snaps up Provention for $2.9 billion »Pfizer snaps up Seagen for $43 billion »Gilead grabs Nurix molecule for $20 million »Flamma launches a $200 million investment campaign »Corteva, Bunge, and Chevron announce canola collaboration »Business Roundup »BMS to conduct research in space »European response to US cleantech incentives leaves industry and environmentalists fuming »IUPAC’s new director discusses how IUPAC comes up with naming recommendations »Fragrance makers under investigation »When do standards of chemical purity break down? »China’s Sinopec marches into green hydrogen »Why lecanemab’s success spells the revival of small-molecule Alzheimer’s treatments »Editorial: What are clicks on our website worth? »Volastra licenses Amgen molecule for chromosomally unstable cancers »The US aims to close its fermentation capacity gap »Lilly inks deal with Confo for GPCR drug candidate »Cargo gets $200 million for CAR T-cell therapy »Biohub launches in Chicago area »Bachem inks peptide supply pact »BASF will expand aroma chemicals in China and Germany »US Steel explores carbon capture with CarbonFree »Solenis to buy Diversey in major water treatment merger »Perstorp moving on low carbon methanol »Membranes raise millions »Lithium prices drive big profits for SQM »DSM assists with foldable bottle »Celanese pushes into drug delivery with 2 deals